What research shows
In a university cohort of 207 NobelActive® implants, overall survival was 91.5%; survival was lower in patients with both local and systemic risk factors (76.5%) than in patients without risk factors (94.8%). 1
Small retrospective study; shows that patient factors matter more than the implant name.
Last updated 28 Sep 2026 · How we review
Sources
- Independent clinical studySaridakis SK et al. Tapered implant with high primary stability in patients with local and systemic risk factors: 7-year data. Int J Implant Dent 2018 — Int J Implant Dent, 2018. Accessed 28 Sep 2026.
- Manufacturer documentationNobel Biocare — Warranty Program (terms for treatment providers) — Nobel Biocare Services AG, 2026-09-28. Accessed 28 Sep 2026.
Educational information only. The choice of implant system depends on your anatomy, restorative plan, bone quality and the clinician's assessment. This website does not recommend a specific implant for you.